• Bagaini F
  • PV 228
  • Septembre 2002

1 - Agence européenne d'évaluation du médicament (EMEA). Rapport d'évaluation sur Virbagen Omega®. 2001 et 2002.
2 - Akiyama K, Sugii S, Hirota Y. A clinical trial of recombinant bovine interferon a1 for the control of bovine respiratory disease in calves. J. Vet. Med. Sci. 1993;55(3):449-452.
3 - Borden EC, Lindner D, Dreicer R et coll. Second generation for cancer: clinical targets. Semin. Canc. Biol. 2000;10:125-144.
4 - Bosio E, Beilharz MW, Watson MW et coll. Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. J. Interferon Cytokine Res. 1999;19(8):869-876.
5 - Bukowski R, Ernstoff M, Gore M et coll. Phase I study of polyethylene glycol (PEG) interferon alpha-2b in patients with solid tumors. Proc. Amer. Soc. Clin. Oncol. 1999;18:446a.
6 - Charley B, Blecha F. Les cytokines : leur rôle dans la régulation du système immunitaire, leur utilisation potentielle chez l'animal. Point Vét. 1991;23(139):71-77.
7 - Chronic Myeloid Leukemia Trialists Collaborative Group. Interferon alpha versus chemotherapy for chronique myeloid leukemia a meta-analysis of seven randomized trials. J. Natl. Cancer Inst. 1997;89:1616-1620.
8 - Cowan JM, Halaban R, Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J. Natl. Cancer Inst. 1988;80:1159-1164.
9 - Cummins JM, Guthrie D, Hutcheson DP et coll. Natural interferon-alpha administred orally as a treatment of bovine respiratory disease complex. J. Interferon Cytokine Res. 1999;19(8):907-910.
10 - Cummins JM, Mock RE, Shive BW et coll. Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study. Vet. Immunopathol. 1995;45(3-4):335-360.
11 - Cummins JM, Hutcheson DP, Cummins MJ et coll. Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus. Arch. Immunol. Ther. Exp. 1993;41(3-4):193-197.
12 - Cummins JM, Tompkins MB, Olsen RG et coll. Oral use of human interferon in cats. J. Biol. Response Mod. 1988;7(5):513-523.
13 - Fields BN, Knipe DM. Fields Virology. 1996:376-399.
14 - Foster GR, Finter NB. Are all type I human interferons equivalent ? J. Viral Hepat. 1998;5(3):143-152.
15 - Gilger BC, Rose PD, Davidson MG et coll. Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjonctivitis sicca in dogs. J. Interferon Cytokine Res. 1999;19(8):901-905.
16 - Hassel BA, Zhou A, Sotomayar C et coll. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects to interferon. EMBO J. 1993;12:3279-3304.
17 - Jayson GC, Middleton M, Lee SM et coll. A randomized phase II trial of interleukine-2 and interleukine-2 + interferon alpha in advanced renal cancer. Br. J. Cancer 1998;78:366-369.
18 - Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncol. 2001;6:34-55.
19 - Jones TH, Wadler S, Hupart KH. Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha. Semin. Oncol. 1998;25(S1):54-63.
20 - Kirkwood JM, Strawderman MH, Ernstoff MS et coll. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST. J. Clin. Oncol. 1996;14:7-17.
21 - Lecce JG, Cummins JM, Richards AB. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Mol. Biother. 1990;2(4):211-216.
22 - Maynard L, De Mari K, Lebreux B. Efficacy of a recombinant feline omega interferon in the treatment of symptomatic FeLV or FeLV and FIV positive cats. Communication ESVIM, Neuchâtel (Suisse). 2001.
23 - Mc Kenna S, Neuteboom B, Tepper M. Enhancement of interferon beta activity by complex formation with the soluble INFA2 interferon subunit. J. Interferon Cytokine Res. 1999;19(S1):155.
24 - Minagawa T, Ishiwata K, Kajimoto T. Feline interferon-omega treatment on canine parvovirus infection. Vet. Microbiol. 1999;69(1-2):51-53.
25 - Nolten WE, Goldstein D, Lindstrom M et coll. Effects of cytokines on the pituituary-adrenal axis in cancer patients. J. Interferon Res. 1993;13:349-357.
26 - Ozes ON, Reiter Z, Klein S et coll. A comparison of interferon consensus-1 with natural recombinant interferon alpha : antiviral, antiproliferative, and natural killer-inducing activities. J. Interferon Res. 1992;12:55-59.
27 - Satoh Y, Kasam K, Khwabara M et coll. Suppression of late asthmatic response by low-dose oral administration of interferon-b in guinea pig model of asthma. J. Interferon Cytokine Res. 1999;19(8):887-894.
28 - Pyrhonen S, Salminen E, Ruutu M et coll. Prospective randomized trial of interferon alpha 2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J. Clin. Oncol. 1999;17:2859-2867.
29 - Steed VP. Improved survival of four cats infected with feline leukemia virus after oral administration of interferon. Feline Practice. 1987;18:135-138.
30 - Tompkins MD, Cummins JM. Response of feline leukemia virus-induced nonregenerative anemia to oral administration of an interferon-containing preparation. Feline Practice. 1982;12:6-15.
31 - Tong K. Research and development of recombinant interferon alpha-1b. J. Interferon Cytokine Res. 1997;17:S63.
32 - Ueda Y, Sakurai T, Yanai A. Homogeneous production of feline interferon in silkworm by replacing single amino-acid code in signal peptide region in recombinant baculovirus and characterization of the product. J. Vet. Med. Sci. 1993;55(2):251-258.
33 - Werner RG, Noe W, Kopp K et coll. Appropriate mammalian expression systems for biopharmaceuticals. Arzneimittelforschung. 1998; 48(8):870-880.
34 - Wood A, Angus B, Kestevan P et coll. Alpha interferon gene deletions in post-transplant lymphoma. Brit. J. Haematol. 1997;98 :1002-1003.
35 - Yamamoto JK, Okuda T, Yanai A. Antifeline herpesvirus and calicivirus effects of feline interferon. J. Interferon Res. 1990;10:S114.

En savoir plus

  • BAGAINI F. Immunologie. Connaître les interférons et leur mode d'action. Point Vét. 2002(227):28-32.
  • Charley B, Blecha F. Les cytokines : leur rôle dans la régulation du système immunitaire, leur utilisation potentielle chez l'animal. Point Vét. 1991;23(139):71-77.
  • VANDAELE E. Parvovirose canine, FeLV-FIV et calicivirose féline. L'interféron oméga augmente la survie lors de viroses graves. Point Vét. 2002;33(223):16-17.